Dustin Wade Wooten, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptor, Serotonin, 5-HT1A | 7 | 2015 | 55 | 1.460 |
Why?
|
Positron-Emission Tomography | 28 | 2022 | 6368 | 1.060 |
Why?
|
Pyridines | 11 | 2015 | 2812 | 0.850 |
Why?
|
tau Proteins | 5 | 2022 | 1859 | 0.850 |
Why?
|
Fluorine Radioisotopes | 7 | 2017 | 447 | 0.740 |
Why?
|
Radiopharmaceuticals | 7 | 2020 | 2688 | 0.710 |
Why?
|
Piperazines | 5 | 2015 | 2486 | 0.700 |
Why?
|
Macaca mulatta | 12 | 2017 | 2384 | 0.600 |
Why?
|
Receptors, Nicotinic | 6 | 2014 | 496 | 0.530 |
Why?
|
Brain | 14 | 2022 | 26350 | 0.520 |
Why?
|
Carbolines | 1 | 2016 | 266 | 0.500 |
Why?
|
Molecular Imaging | 1 | 2016 | 828 | 0.340 |
Why?
|
Pyrroles | 6 | 2014 | 1144 | 0.310 |
Why?
|
Nerve Net | 1 | 2019 | 2178 | 0.300 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2019 | 427 | 0.290 |
Why?
|
Carbon Radioisotopes | 3 | 2019 | 598 | 0.260 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2020 | 561 | 0.220 |
Why?
|
Sex Characteristics | 1 | 2013 | 2585 | 0.210 |
Why?
|
Fluorides | 1 | 2022 | 126 | 0.200 |
Why?
|
Neurons | 1 | 2019 | 9354 | 0.180 |
Why?
|
Neostriatum | 1 | 2019 | 250 | 0.160 |
Why?
|
Tissue Distribution | 3 | 2017 | 2346 | 0.160 |
Why?
|
Isoquinolines | 1 | 2019 | 371 | 0.150 |
Why?
|
Ethanol | 2 | 2014 | 1329 | 0.150 |
Why?
|
Coronary Circulation | 3 | 2020 | 1588 | 0.150 |
Why?
|
Coronary Vessels | 2 | 2020 | 3091 | 0.150 |
Why?
|
Individuality | 1 | 2018 | 304 | 0.150 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2018 | 308 | 0.140 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 381 | 0.140 |
Why?
|
Autopsy | 1 | 2019 | 1005 | 0.130 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 320 | 0.130 |
Why?
|
Pyridazines | 1 | 2017 | 204 | 0.130 |
Why?
|
Rest | 2 | 2017 | 905 | 0.130 |
Why?
|
Kinetics | 5 | 2017 | 6490 | 0.130 |
Why?
|
Deferoxamine | 1 | 2015 | 154 | 0.130 |
Why?
|
Raphe Nuclei | 1 | 2014 | 104 | 0.120 |
Why?
|
Iron Chelating Agents | 1 | 2015 | 141 | 0.120 |
Why?
|
Alzheimer Disease | 3 | 2022 | 7975 | 0.120 |
Why?
|
Physostigmine | 1 | 2013 | 53 | 0.120 |
Why?
|
Protein Binding | 7 | 2015 | 9378 | 0.120 |
Why?
|
Galantamine | 1 | 2013 | 31 | 0.120 |
Why?
|
Lobeline | 1 | 2013 | 1 | 0.120 |
Why?
|
Models, Biological | 3 | 2016 | 9626 | 0.110 |
Why?
|
Geniculate Bodies | 1 | 2014 | 165 | 0.110 |
Why?
|
Animals | 21 | 2022 | 168756 | 0.110 |
Why?
|
Reward | 1 | 2018 | 939 | 0.100 |
Why?
|
Neuroglia | 1 | 2017 | 929 | 0.100 |
Why?
|
Cholinesterase Inhibitors | 1 | 2013 | 239 | 0.100 |
Why?
|
Radioligand Assay | 1 | 2012 | 379 | 0.100 |
Why?
|
Organ Specificity | 1 | 2016 | 2006 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2014 | 3945 | 0.100 |
Why?
|
Dopamine | 1 | 2018 | 1602 | 0.100 |
Why?
|
Radioactive Tracers | 1 | 2011 | 75 | 0.100 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 324 | 0.100 |
Why?
|
Nicotinic Agonists | 1 | 2013 | 271 | 0.100 |
Why?
|
Swine | 5 | 2020 | 5905 | 0.090 |
Why?
|
Stereoisomerism | 1 | 2011 | 630 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2017 | 1406 | 0.090 |
Why?
|
Prefrontal Cortex | 1 | 2018 | 2138 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2014 | 1408 | 0.070 |
Why?
|
Male | 18 | 2019 | 349593 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5524 | 0.070 |
Why?
|
Ligands | 1 | 2012 | 3314 | 0.060 |
Why?
|
Female | 17 | 2019 | 379368 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 8980 | 0.060 |
Why?
|
Self Administration | 2 | 2014 | 386 | 0.060 |
Why?
|
Rats | 5 | 2022 | 24379 | 0.060 |
Why?
|
Computer Simulation | 1 | 2016 | 6253 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19849 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4334 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 4610 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14769 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3254 | 0.050 |
Why?
|
Amyloid beta-Peptides | 1 | 2013 | 3579 | 0.050 |
Why?
|
Nitrogen Isotopes | 1 | 2020 | 85 | 0.050 |
Why?
|
Adult | 6 | 2022 | 213729 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2022 | 548 | 0.040 |
Why?
|
Ammonia | 1 | 2020 | 240 | 0.040 |
Why?
|
Tissue Banks | 1 | 2019 | 184 | 0.040 |
Why?
|
Aged | 4 | 2019 | 162955 | 0.040 |
Why?
|
Dopamine Agents | 1 | 2019 | 190 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 12971 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2014 | 5724 | 0.040 |
Why?
|
Conditioning, Operant | 1 | 2018 | 314 | 0.040 |
Why?
|
Microspheres | 1 | 2020 | 779 | 0.040 |
Why?
|
Humans | 14 | 2022 | 740505 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 35347 | 0.040 |
Why?
|
Middle Aged | 4 | 2019 | 213217 | 0.040 |
Why?
|
Lactams | 1 | 2017 | 156 | 0.040 |
Why?
|
8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2015 | 32 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2020 | 1533 | 0.030 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2015 | 26 | 0.030 |
Why?
|
Cognition | 1 | 2013 | 6691 | 0.030 |
Why?
|
Prazosin | 1 | 2015 | 96 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2017 | 415 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10546 | 0.030 |
Why?
|
Carbocyanines | 1 | 2015 | 176 | 0.030 |
Why?
|
Serotonin Receptor Agonists | 1 | 2015 | 153 | 0.030 |
Why?
|
Adenosine | 1 | 2020 | 820 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2015 | 447 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2016 | 196 | 0.030 |
Why?
|
Cocaine | 1 | 2019 | 1008 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1019 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 542 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2015 | 8328 | 0.030 |
Why?
|
Radiochemistry | 1 | 2012 | 57 | 0.030 |
Why?
|
Markov Chains | 1 | 2016 | 970 | 0.030 |
Why?
|
Brain Mapping | 2 | 2018 | 6666 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2015 | 1894 | 0.020 |
Why?
|
Uncertainty | 1 | 2016 | 722 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 24745 | 0.020 |
Why?
|
Nanostructures | 1 | 2015 | 558 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1183 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3569 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 2028 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3697 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2303 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2017 | 2462 | 0.020 |
Why?
|
Biological Transport | 1 | 2012 | 2127 | 0.020 |
Why?
|
Neural Pathways | 1 | 2018 | 2976 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8317 | 0.020 |
Why?
|
Arteries | 1 | 2012 | 1117 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 56363 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3621 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1968 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6399 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2013 | 1016 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 21558 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 3002 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 2929 | 0.020 |
Why?
|
Cerebellum | 1 | 2012 | 1521 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2017 | 3802 | 0.020 |
Why?
|
Mice | 3 | 2017 | 81104 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4574 | 0.020 |
Why?
|
Contrast Media | 1 | 2017 | 5293 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10953 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 40437 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6114 | 0.010 |
Why?
|
Glucose | 1 | 2013 | 4385 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16684 | 0.010 |
Why?
|
Registries | 1 | 2013 | 8043 | 0.010 |
Why?
|
Genetic Variation | 1 | 2013 | 6549 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13277 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57769 | 0.010 |
Why?
|
Risk Factors | 1 | 2013 | 72030 | 0.000 |
Why?
|